Table 3.
Response | Sorafenib adjuvant therapy n = 7 |
Historical comparison group n = 12 |
P value |
---|---|---|---|
Recurrent HCC (%) | 2 (29) | 9 (75) | 0.07 |
Median recurrent time from OLT (days) | 1053 | 620 | 0.08 |
1-year disease-free survival | 7 (100) | 8 (66) | |
1-year overall survival (%) | 7 (100) | 11 (91.6) | 0.63 |
Mean follow-up duration in days (SD) | 1125 (310) | 840 (483) | 0.18 |